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The oncogene c-MYC has guanine-rich and complementary cytosine-rich
sequences in its P1 promoter region. The P1 promoter is responsible for over 90% of the
c-MYC expression. Downregulation of c-MYC expression represents a novel therapeutic
approach to more than 50% of all cancers. A stable i-motif formed by the c-MYC C-rich
sequence would be an attractive target for cancer treatment. We have previously shown
that c-MYC promoter sequences can form stable i-motifs in acidic solution (pH 4.5-5.5).
The question is whether c-MYC promoter sequence i-motif will be stable at physiological
pH.
In this work, we have investigated the stability of mutant c-MYC i-motif in
solutions having pH values from 4 to 7 and containing co-solutes or molecular crowding
agents. The crowded nuclear environment was modeled by the addition of polyethylene
glycol (PEG, having molecular weights from 200 to 12000 g/mol) at concentrations of
10% to 40% w/w.

Circular dichroism spectroscopy (CD) and differential scanning calorimetry
(DSC) were used to establish the presence and stability of c-MYC i-motifs in buffer
solutions having pH values of 4 to 7. The results of these studies are: 1) the addition of
up to 20% w/w glycerol does not increase i-motif stability, 2) the addition of 30% PEG
results in an increase in i-motif stability to pH values as high as 6.7, 3) i-motif stability is
increased with increased PEG concentration and increased PEG molecular weight, and 4)
the effects of PEG size and concentration are not linear, with larger PEGs forming
DNA/PEG complexes, which destabilize the i-motif.
In summary, we have shown that the c-MYC i-motif can exist as a stable structure
at pH as high as 6.7 in a crowded environment. Molecular crowding, largely an excluded
volume effect, drives the formation of the more compact i-motif, even at higher pH
values where the cytosine imino-nitrogen is deprotonated and neutral C-C pairs can form
only two H-bonds. Based on this research, it seems possible that a stable c-MYC
promoter sequence i-motif could form at physiological pH and would be a reasonable
drug target for new cancer therapies.
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CHAPTER I
INTRODUCTION

Cancer, now one of the biggest killers in the world, is a broad group of more than
200 diseases that have several features in common. These features include accelerated
metabolism, uncontrolled growth, the loss of signals for tissue density or cell apoptosis,
the growth of new vasculature, and the immortalization of cancer cells. Cancer
sometimes results from damage to DNA in normal cells or by the expression of genes
that are normally silent (e.g. oncogenes) [1,2,3]. Normal cells typically follow specific
and regular steps in their life cycle: growth, deviation and death. Cancer cells jump out of
this cycle and become immortal i.e. the cancer cell lifecycle includes continuous growth,
deviation and invasion. Cancer cells not only invade tissues nearby, but can also relocate
to other parts of the body through lymphatic and circulatory systems, a process known as
metastasis [4,5]. Adding to the complexity, cancers located in different parts of the body
also behave very differently, e.g. lung cancer and breast cancer are quite different in their
types of tumors formed, their growth rates, and their response to different therapeutic
treatments or strategies.
The unpredictability and variability of cell transformation from normal cells to
cancer cells with their inherently more rapid metabolism, faster growth rates, and
immortality makes cancer very difficult to cure. So far, the most common treatments for
cancer are a combination of surgery, chemotherapy, and radiation therapies [6]. In some
1

cases, these treatments are highly effective in curing the most treatable cancers; however
some of these treatments are accompanied by side effects that are often as debilitating as
the cancer itself.
Chemotherapy involves treating patients with one or more cytotoxic medications
that will kill both normal and cancer cells. The hope is that the anticancer drug will be
more effective at killing cancer cells that are dividing more rapidly, than the healthy cells.
Chemotherapy is not very specific or selective but can be highly effective when used
together with surgery or radiation therapy.
Radiation therapy involves exposing the patient to ionizing radiation directed at
the site of the tumor or malignancy. The ionizing radiation damages the DNA in the
exposed cells, leading to the death of both cancer and normal cells that were exposed to
the radiation. The obvious side effect of both chemotherapy and radiation therapy is that
they may damage normal tissues when applied. Radiation and chemotherapy may also
alter the functions of certain biological systems, such as bone marrow (reducing white
blood cells, red cells and platelets) and hair follicles (hair loss) [7]. Since it is necessary
to include a margin of normal tissue around a tumor, high doses of radiation may
subsequently cause damage to the normal tissue [8,9]. All of these resulting side effects
give patients pause before they decide on which therapeutic course to take. Surgery also
has its limitations: it works better before cancer cells metastasize since it is almost
impossible to remove all the cancer once it has spread.
The side effects of existing cancer treatments have encouraged researchers to look
for better ways to cure cancer. The newest trends in cancer treatment are targeted cancer
therapies. Targeted therapies are small molecule drugs that distinguish cancer cells from
2

normal cells, by interfering with the processes that control the growth, division and
apoptosis of the cancer cells. Targeted therapies theoretically have little effect on normal
cells. To date, there are three categories of tumor targeting medications that are under
investigations. The first category targets growth signal inhibition. Some enzymes can
work as growth signals and are overproduced in cancer cells. Inactivation of these
enzymes or blocking the receptors of these enzymes will efficiently slow down the
growth of the cancer cells. Most targeted therapy medications on the market today belong
to this category, such as bortezomib (Velcade) [10,11]. Velcade is a dipeptide and
proteasome inhibitor. Proteasome maintains the immortal phenotype in cancer cells. By
blocking this enzyme, misfolded or abnormal proteins will accumulate in cancer cells,
and eventually permit cell death [12, 13]. Another growth signal blocker is the drug
gefitinib (Iressa) [14,15]. Iressa targets the epidermal growth factor receptor by binding
to the adenosine triphosphate (ATP)-binding site of the enzyme [16,17].
The second category of targeted therapy is angiogenesis inhibition. Angiogenesis
is the process of making new blood vessels in the body. As for a healthy adult, this
function is not of great importance, but in cancer cells, this function is over activated to
provide the cancer cells with its own blood supply. Sunitinib (Sutent) is a multi-targeted
receptor tyrosine kinase (RTK) inhibitor [18,19]. By inhibiting cellular signaling, Sutent
reduces tumor vascularization which ultimately leads to cell death [19,20].
The third category of targeted therapy is apoptosis-inducing drugs. Apoptosis is
defined as programmed cell death. Rather than dying due to injury, cells that go through
apoptosis die in response to signals within the body. Triggering apoptosis in cancer cells
is the method that drugs in this category will use to treat the disease. Apoptosis targets
3

that are currently being explored for cancer drug discovery include the tumor-necrosis
factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors, the BCL2 family of
anti-apoptotic proteins, inhibitor of apoptosis (IAP) protein.
The apoptosis process is regulated by many factors, besides the enzymes
mentioned in the previous paragraphs. Other factors include K-Ras [21], Bcl-2 [22] and
c-MYC [23]. We are particularly interested in the c-MYC gene. Located on the human
chromosome 8 [24], the c-MYC gene is responsible for expressing a transcription factor
that can regulate many genes that will further affect cell function, cell growth and
apoptosis. The c-MYC gene is overexpressed in a wide variety of cancers with 80% of
breast cancers, 70% of colon cancers and 90% of cervical and ovarian cancers possessing
abnormal c-MYC expression [25,26]. It has been reported that the amount of c-MYC
expression is a key to control the apoptosis: reducing the expression of c-MYC gene will
directly induce apoptosis [27,28]. The possibility of regulating apoptosis points to cMYC as an ideal target in targeted cancer therapy. If the expression of c-MYC gene in
the cancer cells can be down-regulated, the apoptosis of cancers cells will be reinitiated.
Understanding the transcription and expression processes of the c-MYC gene will
be a key to regulate its expression. The transcription of c-MYC gene involves multiple
promoters (P0, P1, P2, P3), several cis-elements (e.g. the far upstream element, FUSE),
some proteins (e.g. the FUSE-binding protein, FBP) and some nuclease hypersensitive
elements (NHE I, II1, II2, III1, III2, IV, V). The FUSE, located ~1.7 Kbp upstream of P2
promoter, is reported to be single-stranded during the transcription of the c-MYC gene,
and remains double stranded when the gene is not transcribed [29,30]. The FBP could
bind with FUSE when it is single-stranded, and the binding will further activate the
4

transcription of the c-MYC gene [30]. One of the nuclease hypersensitive elements, NHE
III1, is believed to control over 90% of the c-MYC gene transcription [31,32]. The NHE
III1 is located ~142-~115 bp upstream of P1 promoter, and can possibly form non-BDNA structures, due to its cytosine-rich and guanine-rich strands.
B-DNA is the most common form of DNA, in which the double helix twists in a
right-hand direction. C (cytosine)-rich and G (guanine)-rich strands of human telomeric
DNA have been reported to form non-B-DNA structures. The structures formed are
called i-motif and G-quadruplex, respectively. As shown in Figure 1.1a, hydrogen
bonding is formed between the four guanines to make a G-quartet, and these G-quartets
stack on one another to form the G-quadruplex. The structure of i-motif is shown in
Figure 1.1b. Two cytidine stretches form a parallel-stranded duplex with {Cyt-3N+-H /
N3-Cyt} pairs and two such duplexes associate head-to-tail by base-pair intercalation
into a quadruplex. The i-motif is the only known nucleic acid structure involving
systematic base intercalation and usually forms at acid or neutral pH. While the Gquadruplex has gotten considerably more attention since the structure was discovered, we
would like to focus on the i-motif formed by the complementary strand. To date, the
studies that have been done on the i-motif structure have focused on its geometry,
symmetries and topologies and subsequent stability. The typical structure of the i-motif,
as shown in the Figure 1.1b, has been confirmed by NMR [33,34], X-ray crystallography
[35,36], and FRET [37]. It has been proved that the typical i-motif structure is most stable
in acidic diluted solution (pH 4.5-5.5) [38,39,40]. The stability of the typical i-motif
structure will decrease when the pH of the solution increases, due to the loss of the hemiprotonated {Cyt-3N+-H / N3-Cyt} pair [37,41,42,43].
5

Figure 1.1

The structures of G-quadruplex (a) and i-motif (b). [44]

Thus far, most of the studies of i-motif structure and stability have been done on
oligonucleotides in dilute buffer solutions with little or no co-solute present. However,
the nuclear solution environment is anything but dilute. Macromolecules, e.g. DNA,
various RNAs, and numerous proteins are present in the nucleus, with water accounting
for only 60% of the solution mass in the nucleus [45,46]. The nuclear solution is more
like a gel, with these macromolecules contributing to the nuclear solution properties, i.e.
density, viscosity, and bulk dielectric constant. The principle difference between smaller
co-solutes and these larger macromolecules is that the polymers have much larger
excluded volume effects. The excluded volume will affect the chemical and biochemical
6

reactions happening in the cell [46,47]. It may also affect the reaction rate, the water
activity and the equilibrium of the reaction [48-52]. The stability of the i-motif structure
in diluted solutions and in crowded solutions may be different. The crowding intracellular
environment has to be considered in our research. It is necessary to add molecular
crowding agents into diluted solutions in order to mimic the intracellular environment.
In order to act as a reliable molecular crowding agent, the macromolecule should
have an adequate molecular weight range, should be soluble in water at high
concentrations, should not aggregate, should consist of globular molecules and should not
interact with reacting molecules [46]. Some polymers that have been used as crowding
agents include polyethylene glycol (PEG), dextran and ficoll [53,54]. Some proteins and
polypeptides have also been utilized as crowding agents, such as hemoglobin, myoglobin,
albumin and polylysine [46,55].
Considerable research has already been done on the effects of molecular
crowding agents on DNA and proteins. By adding macromolecules, protein folding is
accelerated but folding efficiency reduced by the increase in protein aggregation
[56,57,58] protein-protein interactions [59] or protein-DNA interactions [60] and the
stability of RNA [61] and the activity of DNA polymerase [62] are increased. Molecular
crowding with PEG also induces the formation of G-quadruplex [63-67]. However, data
for i-motif structures in a crowded environment is still quite limited.
The idea of using i-motif forming sequences (C-rich sequences), located on the
NHE III1 P1 region, as a target for cancer treatment, is based on the existence of a stable
i-motif structure in the nucleus at neutral pH. If a stable i-motif structure can be formed
by the NHE III1 P1 region of the c-MYC oncogene, it is likely to inhibit the promoter and
7

turn off the transcription of the c-MYC gene, as shown in Figure 1.2. Once the
transcription of c-MYC gene is down regulated, the expression of the c-MYC gene will
also be down regulated, resulting in induced apoptosis.

Figure 1.2

The equilibrium between the transcriptionally inactive form and the
transcriptionally active form of the double stranded C-rich and G-rich
sequences.

In this work, we investigated the stability of the i-motif structure in a
macromolecular crowded environment. Different molecular weights and concentrations
of molecular crowding agent polyethylene glycol (PEG) were added to dilute BPES
buffer, in order to mimic the crowded intracellular environment. The pH values of these
buffers were adjusted over a range from 4 to 7 in order to study the stability of the i-motif
structure at physiological pH. The osmolyte glycerol was also used as a crowding agent
for comparison.
First, we investigated if the crowding environment would affect the stability of
the i-motif structure by comparing the melting temperature of the i-motif structure in
8

diluted BPES buffer and in 20% w/w PEG containing BPES buffer. The PEGs used in
this part had molecular weights from 200 to 4000 g/mol. We also studied the structure of
the C-rich sequence formed in the solutions, to verify that it was a typical i-motif. The
melting temperature was measured by differential scanning calorimetry (DSC) and the
structure of the C-rich sequence formed in the buffer was confirmed by circular
dichroism (CD).
Secondly, we used a different crowding agent, glycerol, to investigate the reason
for the increased stability of the i-motif structure in a crowded environment. Glycerol was
added into dilute BPES buffer at 20% w/w, and the pH values were adjusted to the same
values as the PEG-containing buffers. Both glycerol and the PEG-containing buffers
exhibited the same co-solute effect, due to the very similar dielectric constant values in
the 20% water mixture solutions. The only difference between PEG buffers and glycerol
was the excluded volume effect, which only pertained to the PEG-containing buffers
(PEG size). Comparisons between PEG and glycerol would identify the driving force for
the increased stability of the i-motif structure in the PEG-containing buffers.
Thirdly, we investigated the effect of PEG concentrations on the stability of the imotif structure. We applied PEG8000 at four different concentrations (0%, 20%, 30% and
40% w/w) to study if the stability of the i-motif structure would be affected.
Lastly, we investigated the effect of the molecular weight of PEG on the stability
of the i-motif structure. At the beginning of this study, we noticed that higher molecular
weight PEG further stabilized the i-motif structure. Here we applied PEG12000 at 10%,
20% and 30% w/w to investigate if the larger PEG would result in an even higher
stability of the i-motif structure.
9

We anticipate that our study will give a clear picture of the effect of
macromolecular crowding on the stability of the i-motif structure, as well as the
possibility for the i-motif structure to be stabilized under physiological conditions. The
key point of this study is to evaluate the possibility of the i-motif forming sequence on
the NHE III1 P1 region of the c-MYC gene becoming a potential therapeutic target in
cancer treatment research.
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CHAPTER II
MATERIALS AND METHODS

In this study, differential scanning calorimetry (CD), circular dichroism (CD) and
ultraviolet-visible spectroscopy (UV) were primarily used. In this chapter the theory of
each technique will be introduced briefly, and the experimental details will be listed as
well.
Introduction of techniques
Differential Scanning Calorimetry (DSC)
Differential scanning calorimetry (DSC) is a thermodynamic technique that can
measure the energy transferred to or from a sample undergoing a physical or chemical
change. Temperature differences between the reference cell and the sample cell are
measured as a function of time and result in transition heat capacity, enthalpy and Tm.
DSC is often used to study the transitions of macromolecules, such as DNA and proteins,
from the folded state to the unfolded state [68].
Figure 2.1 is a schematic of the instrument. The sample cell and the reference cell
are identical but separated and isolated. The sample cell is loaded with sample. The
reference cell is loaded with exactly the same buffer used to prepare the sample. In a
DSC experiment, the sample cell and the reference cell need to loaded with identical
volumes. The power source will provide the heat to increase the temperature of both
11

cells. The temperature sensors will detect the temperature difference between the sample
cell and the reference cell (∆T). If the temperature sensor detects the existence of ∆T, the
heater will apply compensating power, and the compensation signal will be reported as
heat flow vs. temperature in microwatts or joules [68].

Figure 2.1

A schematic of the DSC instrument [69].

After analyzing the calorimetric output, the values of the melting temperature
(Tm), the calorimetric enthalpy (∆Hcal) and the Van’t Hoff enthalpy (∆HVH) can be
reported. The Tm indicates the temperature where 50% of the macromolecules are
unfolded and 50% are still folded. The ∆Hcal indicates the energy needed to finish this
transition. The ∆HVH could help to understand the unfolding process of the
macromolecule: if the ratio ∆HVH/∆Hcal is less than one, it indicates there may be
intermediate states; if the ratio is greater than one, the melting process may be
12

cooperative [68]. The calculations of ∆Hcal and ∆HVH can be done using the equations
below [68]:
𝑇𝑢

∆Hcal = ∫𝑇0 𝐶𝑝𝑑𝑇
∆HVH = 4RTm2

Cp(m)
∆Hcal

(2.1)
(2.2)

In equation 2.1, T0 and Tu are the temperatures of the starting and finishing points
of the transition. Cp is the excess heat capacity, which can be understood as the heat
capacity only for the macromolecule in the melting process. In equation 2.2, Tm is the
melting temperature and the Cp(m) is the maximum value of excess heat capacity [68].
Circular Dichorism (CD)
Circular dichroism spectroscopy (CD) measures the differences in the absorption
of left-handed polarized light versus right-handed polarized light, which is due to the
structural asymmetry of the macromolecule. CD is particularly good for determining
whether a protein is folded and what its conformational stability is under stress (thermal
changes, pH changes and overcrowding). Secondary structures can also be determined by
CD spectroscopy in the "far-UV" spectral region (190-250 nm) [70]. Ordered structures,
such as proteins and DNAs have their own unique CD signals, containing several positive
and negative peaks. If the absorption of the left handed polarized light is greater than the
absorption of the right handed polarized light, the peak will be positive; a negative peak
has the absorption of the right-handed light greater than the left. Figure 2.2 shows a
schematic of the CD instrument. The linear light will be converted to L- and R- handed
polarized lights by the phone elastic modulator (PEM), and the macromolecule will
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absorb the two polarized lights differently, and be detected by the phone multiplier tube
(PMT).

Figure 2.2

A schematic of the circular dichroism instrument.

Ultra-Visible Spectroscopy (UV)
Ultraviolet-visible spectroscopy is a very useful technique to identify the
concentration of a given solution based on the absorption of ultraviolet-visible light.
Beer’s Law, A=ε×b×C, indicates that the absorption of the light, A, is proportional to the
molar absorption value of the given solution, ε, the path length of the container, b, and
the molar concentration, C [70,71]. In this study, the concentrations of all DNA samples
were determined by UV-visible spectroscopy, using a ε value of 198,200 M-1cm-1.

14

Experimental details
Design DNA sequence:
The mutant human c-MYC promoter i-motif forming sequence used in this study
was designed based on the results of previous research. Previously we used a mutant
sequence, Mut, in which there were 3 C → T mutations and 2 C → A mutations. The
purpose of these mutations was to simplify the folding and hopefully end up with a cMYC promoter sequence that exhibited only a single i-motif folded conformer. The
wild type (WT) sequence has multiple repeated cytosines, which can interact to form
more than one i-motif or “i-motif like” structure. In order to simplify the model, we
designed Mut with the above listed 5 mutations and MutA with 7 point mutations,
including two additional C → T mutations. The sequences for the 5-base and 7-base
mutants are listed in Table 2.1. DSC results indicate that there are three different
structures formed by the 5 mutant sequence (see Figure 2.3), while only a single structure
is formed by the melting of the 7 mutant sequence (see Figure (2.5). In Figure 2.4, we
show the three different i-motif structures that can result from folding the Mut sequence
into an i-motif [38]. In Figure 2.4 panel A, we show the single i-motif structure that result
from folding of the 7 mutant sequence. In Figure 2.6 we show the characteristic CD
signature spectrum for formation of the single i-motif that can be formed by the MutA
sequence used in the present study.

15

Table 2.1

A scheme of the wild-type (WT) 23mer human c-MYC promoter i-motif
forming sequence and its two mutant sequences: Mut (5 mutations, shown in
red) and MutA (7 mutations, shown in red).
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

WT

5’ C T T C C C C A C C C T C C C C A C C C T C C 3’

Mut

5’ C T T T C C T A C C C T C C C T A C C C T A A 3’

MutA 5’ T T T T C C T A C C C T T C C T A C C C T A A 3’

Figure 2.3

DSC melting curve of the mutant of human c-MYC promoter sequence,
Mut, at pH 5.0 in 130 mM K+ BPES buffer.
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Figure 2.4

The computational simulations of the three i-motif and “i-motif like”
structures formed by the Mut sequence in 130 mM K+ BPES buffer at pH
5.0.

Figure 2.5

The DSC melting curve of the i-motif structure formed by the MutA
sequence in 130 mM K+ BPES buffer at pH 5.0.
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Figure 2.6

The CD spectrum of the i-motif structure formed by the MutA sequence in
130 mM K+ BPES buffer at pH 5.0.

Preparation of buffers:
BPES buffer
130 mM K+ BPES buffer was prepared using KH2PO4, K2HPO4, KCl, EDTA (for
one liter of buffer). The solution was filtered right after being made, and was divided into
several bottles. The pH values of each of the buffers were adjusted to the correct pH by
adding NaOH or HCl. A pH meter was used to verify the pH values.
PEG/glycerol containing buffer
BPES buffer containing 20% w/w glycerol, 20% w/w PEG200, PEG400, PEG1000,
PEG2000, PEG4000, PEG8000, 30% w/w PEG8000, 40% w/w PEG8000, 10% w/w PEG12000,
20% w/w PEG12000 and 30% w/w PEG12000 were used in this study. The mass of certain
amount of BPES buffer was measured, and the mass of co-solute was calculated based on
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the desired concentration. The PEG containing buffer was made by adding BPES buffer
and the co-solute together, and then was divided into several bottles to adjust pH values
Preparation of DNA samples:
Stock DNA samples
The lyophilized deoxyoligonucleotides (sequence: 5’- TTT TCC TAC CCT TCC
TAC CCT AA -3’) were purchased from The Midland Certified Reagent Company, Inc.
(Midland, TX). The oligonucleotides were dissolved in 1ml of each buffer to make a
stock DNA solution. DNA concentrations in the stock solution were verified by
ultraviolet-visible spectroscopy (Hewlett Packard 8452A Diode Array
Spectrophotometer) using the molar extinction coefficient ε260=198,200 M-1cm-1.
DSC samples
The DSC samples were made from stock DNA solutions and the accompanying
buffers. The nominal concentration for each DSC sample was 250 μM. The
concentrations of the DSC samples were verified before each DSC experiment.
CD samples
The CD samples were extracted from the post-DSC samples, which are collected
after each DSC experiment. The nominal concentration for each CD sample was 3 μM. In
some experiments (PEG8000 and PEG12000 CD titration experiments), CD samples were
also made up from the pre-DSC samples.
The CD titration samples were extracted from the leftover pre-DSC samples for
each PEG8000 containing buffer. The pH of each pre-DSC sample was corrected to 4.0
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before making the CD samples. The nominal concentration for each CD sample was 3
μM.
DSC experiments:
DSC experiments were run on a Microcal VP-DSC (Piscataway, NJ). The DSC
experiments were done over a temperature range from 10-90°C at a scan rate of 90°C/h.
There were 3 scans for each DSC experiment in order to ensure reproducibility. The data
was analyzed with Origin 7 (Microcal, St. Louis, MO) in order to determine the melting
temperature (Tm) for every DNA sample.
CD experiments:
CD experiments were run on an Olis DSM 20 CD spectroscope (Bogart, GA).
The CD spectra were collected at 20°C over the wavelength range of 200 to 325 nm with
constant N2 gas flow. Data was analyzed using Olis GlobalWorks (Olis, Bogart, GA) and
GraphPad Prism 5 (La Jolla, CA).
CD titration experiments:
The CD titration samples had an initial pH value around 4.0. NaOH was added
between scans to adjust the pH values gradually from 4.0 to 6.5 or higher. The
microprobe pH meter was used to detect the pH value of the CD sample for each scan.
The mixing time between scans were under 2 min. Data was also analyzed by using Olis
GlobalWorks (Olis, Bogart, GA) and GraphPad Prism 5 (La Jolla, CA).
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CHAPTER III
RESULTS

The melting temperatures (Tms) for the c-MYC i-motif were determined in
solutions having pH values of 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, and 7.0 using DSC. In these
experiments, the solution was a 130 mM K+ BPES buffer adjusted to the pH of interest
and containing either no added co-solute or 20% w/w PEG. In Figure 3.1 we have
plotted the measured i-motif Tm at the seven specific pH values for each of the five
solutions (no added PEG, PEG200, PEG400, PEG1000, PEG2000 and PEG4000). The i-motif is
stabilized (Tm is increased) at all pH values above 4.5 by the addition of PEG. Obviously
the Tm is dependent on pH in all solutions. In the mid pH range, the Tm measured is for
the unfolding of the i-motif while at higher pH values (i.e. pH > 6.0) the structure that is
heat denatured is i-motif like and clearly not a classical i-motif structure. (CD
experiments were used to determine whether the higher order nucleic acid structure was a
true i-motif.) The lowest pH data show an anomaly in that at pH 4.0, where the cytosine
pair is more completely protonated, the addition of PEG destabilizes the i-motif
significantly (ΔTm ≈ -8ºC for PEG200). At pH 6.5 (and above), where the i-motif is less
stable since the cytosine pair is no longer hemi-protonated, the addition of PEG result in
stabilization of the “i-motif like” structure. The increase in i-motif stabilization at pH
values above 4.5 exhibits a trend in that stabilization of the i-motif is increased as the
molecular weight of the PEG is increased. The decrease in i-motif stabilization at pH
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values below 4.5 follows the same trend but with the complication that the addition of
lower molecular weight PEGs destabilize the i-motif, and this destabilization is reversed
as the PEG molecular weight is increased.

Figure 3.1

Melting temperatures (Tms) of a c-MYC mutant promoter sequence i-motif
DNA construct in BPES buffer with added PEG (20% w/w).

Notes: Black: Tms of the structure formed in BPES buffer. Pink: Tms of the structure
formed in 20% w/w PEG200 solutions; Dark blue: Tms of the structure formed in 20%
w/w PEG400 solutions. Red: Tms of the structure formed in 20% w/w PEG1000 solutions.
Green: Tms of the structure formed in 20% w/w PEG2000 solutions. Light blue: Tms of the
structure formed in 20% w/w PEG4000 solutions.
CD experiments were used to establish the presence of the i-motif DNA structure
in solution. The characteristic CD spectrum for i-motif DNA exhibits a maximum
ellipticity at (or near) 286 nm while the “i-motif-like” DNA structure exhibits a
maximum ellipticity at (or near) 275 nm. The CD spectra shown in Figure 3.2 are for
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solutions having pH values of 4.0, 4.5, 5.0, 5.5, 6.0, 6.5 and 7.0. The CD spectrum in
buffer without PEG is consistent with previously published results in that the typical imotif structure is observed in more acidic solutions (pH 4.5 to 5.5) while the i-motif
structure is lost at pH 6.0 and higher. The CD spectra for the mutant c-MYC i-motif
forming sequence in 20% PEG solutions shows that at pH 6.0, the DNA sequence is
folded into the characteristic i-motif structure typically formed by C-rich sequences at
lower pH values where the cytosine pairs are hemi-protonated. The addition of molecular
crowding, e.g. PEG, is apparently driving the folding/unfolding toward formation of the
compact i-motif structure even though the cytosine pairs at this pH, pH ≥ 6.0, are largely
deprotonated.
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Figure 3.2

CD spectra of the c-MYC mutant promoter sequence i-motif DNA
construct in BPES buffer with and without added PEG (20% w/w).
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Figure 3.2 (continued)
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Figure 3.2 (continued)
Notes: In all solutions, Red: the CD spectra of the DNA structure at pH 4.0. Dark blue: the CD
spectra of the DNA structure at pH 4.5. Light blue: the CD spectra of the DNA structure at pH
5.0. Purple: the CD spectra of the DNA structure at pH 5.5. Green: the CD spectra of the DNA
structure at pH 6.0. Orange: the CD spectra of the DNA structure at pH 6.5; Black: the CD
spectra of the DNA structure at pH 7.0.
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The melting temperatures (Tms) for the c-MYC i-motif were again determined in
glycerol-containing solutions having pH values of 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, and 7.0,
using DSC. In these experiments the solution was a 130 mM K+ BPES buffer adjusted to
the pH values of interest and containing 20% w/w glycerol as the added co-solute. In
Figure 3.3 we have plotted the melting temperatures, Tms, for unfolding of the c-MYC imotif at the seven specific pH values in BPES buffer without added co-solute and in the
glycerol-containing solutions. The Tms for the mutant c-MYC i-motif forming sequence
in glycerol solutions indicate that in comparison to the Tms determined in buffer without
co-solute, the i-motif structure is destabilized at pH values 4.0 and 4.5, and stabilized at
pH 5.5. CD spectra obtained for the mutant c-MYC i-motif forming sequence in these
same solutions (with and without added glycerol) are shown in Figure 3.4. The
characteristic i-motif spectrum is observed in glycerol containing solutions at pH values
of 4.0 to 5.5. At pH 6.0, the CD spectrum in glycerol is a mixture of the characteristic imotif spectrum and the “i-motif like” spectrum observed at higher pH values.
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Figure 3.3

Tms for the c-MYC mutant promoter sequence i-motif DNA construct in
BPES buffer with and without added glycerol (20% w/w).

Notes: Black: the Tms of the structure formed in BPES buffer. Red: the Tms of the
structure formed in 20% w/w glycerol solutions.
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Figure 3.4

CD spectra for the c-MYC mutant promoter sequence i-motif DNA
construct in BPES buffer with added glycerol (20% w/w).

Notes: Red: the CD spectra of the DNA structure at pH 4.0. Dark blue: the CD spectra of
the DNA structure at pH 4.5. Light blue: the CD spectra of the DNA structure at pH 5.0.
Purple: the CD spectra of the DNA structure at pH 5.5. Green: the CD spectra of the
DNA structure at pH 6.0. Orange: the CD spectra of the DNA structure at pH 6.5; Black:
the CD spectra of the DNA structure at pH 7.0.
In Figure 3.5, we show the spectra of the CD titration experiments applied to the
DNA structure formed by mutant human c-MYC promoter sequence in various buffer
solutions. The results show that in BPES buffer with no added PEG8000, the typical imotif structure was last detected at pH 5.9 (Figure 3.5A); in BPES + 20% w/w PEG8000
buffer, the typical i-motif was last seen at pH 6.10 (Figure 3.5B); in BPES + 30% w/w
PEG8000 buffer, the tolerated pH value of the stable i-motif goes up to ~pH 6.6 (Figure
3.5C); and in BPES + 40% w/w PEG8000 buffer, the stable i-motif structure can not exist
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in solution with pH value higher than 6.1 (Figure 3.5D). The CD results show a trend that
adding higher concentration of PEG8000 in BPES buffer will end up with a higher pH
value of the solution in which the stable i-motif can exist; but this trend only works for
the buffers containing 0-30% w/w PEG8000. In 40% w/w PEG8000 containing buffer, the imotif cannot exist in solutions with pH value higher than 6.1. We think it is because of
the formation of an additional DNA/PEG complex (Figure 3.7) and the shifting of the
equilibrium for the i-motif/complex formation reactions in the 40% w/w PEG8000 buffer.
The CD results indicate that the formation of typical i-motif structure is not only
depending on the concentration of added PEG8000 in the solution. High concentration (e.g.
40% w/w) could reduce the formation of stable i-motif structure in the buffer solution,
but at lower concentrations (20-30% w/w), it seems to be that increasing the
concentration of PEG will increase the suitable pH value for the stable i-motif structure.
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Figure 3.5

The spectra of the CD titration experiments applied to the DNA structure
formed by mutant human c-MYC promoter sequence in 0-40% w/w
PEG8000 containing buffer solutions (A, 0%; B, 20%; C, 30%; D, 40%).
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Figure 3.5 (continued)
Notes: A: Black: pH 4.50; Red: pH 5.60; Orange: pH 5.75; Yellow: pH 5.81; Light green: pH
5.84; Dark green: pH 5.92; Light blue: pH 5.99; Dark blue: pH 6.08; Purple: pH 6.21. B: Black:
pH 4.17; Red: pH 4.57; Orange: pH 5.53; Yellow: pH 5.98; Light green: pH 6.05; Dark green:
pH 6.10; Light blue: pH 6.21; Dark blue: pH 6.29; Purple: pH 6.52; Pink: pH 7.01. C: Black: pH
4.04; Red: pH 5.48; Orange: pH 6.06; Yellow: pH 6.43; Light green: pH 6.58; Dark green: pH
6.66; Light blue: pH 6.71; Dark blue: pH 6.92. D: Black: pH 4.02; Red: pH 4.23; the Orange:
pH 5.01; Yellow: pH 5.95; Light green: pH 6.08; Dark green: pH 6.13; Light blue: pH 6.25; Dark
blue: pH 6.38; Purple pH 6.55.
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Table 3.1
pH
4.5
5.0
5.5
6.0
6.5

The melting temperatures of i-motif in PEG8000 containing buffers having
different concentrations.

Tm (˚C) of i-motif Tm (˚C) of i-motif Tm (˚C) of i-motif Tm (˚C) of i-motif
in BPES buffer w/o in solutions w/ 20% in solutions w/ 30% in solutions w/ 40%
PEG
PEG8000
PEG8000
PEG8000
45.6
50.9
53.5
58.4
41.5
50.4
52.5
57.3
33.4
46.2
49.8
58.7
23.0
32.5
42.3
50.4
11.2
17.7
38.2
37.9

In Figure 3.6, we plotted the measured melting temperatures (Tms) (Table 3.1) of
the DNA structure formed by the mutant human c-MYC promoter C-rich sequence in
various buffer solutions at five specific pH values (4.5, 5.0, 5.5, 6.0 and 6.5). The buffer
solutions were made of 130 mM K+ BPES buffer, in addition of PEG8000 at different
concentrations (0%, 20%, 30% and 40% w/w), and each concentrated PEG containing
buffer was further adjusted to 5 specific pH values (4.5, 5.0, 5.5, 6.0 and 6.5). The same
observation can be made as previous study that the Tms of the DNA structure formed by
the mutant human c-MYC promoter C-rich sequence at high pH values (6.0 and 6.5) are
lower than the Tms in acidic conditions (4.5 - 5.5) in each concentrated PEG buffers. The
observation indicates that the stability of the i-motif structure, in terms of melting
temperatures, is higher in acidic conditions. If we compare the Tms of the DNA structure
in 4 different solutions at each pH value, it is obviously to notice a trend that the Tms are
increased together with the increasing concentration of PEG8000 in the solution. The
stability of the DNA structure formed by the C-rich sequence is increasing as the result of
adding higher concentration of PEG8000 in the buffer solutions. There is only one
exception, that is the Tm of the DNA structure formed in pH 6.5 40% w/w PEG8000
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solution (Tm6.5-40%), which is almost the same as the Tm of the DNA structure formed in
pH 6.5 30% w/w PEG8000 solution (Tm6.5-30%). If following the trend, the Tm6.5-40% should
be higher than the Tm6.5-30%, indicating the higher stability of the structure in the solution.
The reason for this decreasing of Tm6.5-40% can also be explained as the formation of the
complex (Figure 3.7). As conformed by CD results (Figure 1A-D), we can tell that at pH
4.5 - 5.5, the stable i-motif structure is existing in all solutions, and its stability is
proportional to the concentration of PEG8000 contained in the solution. We would like to
focus our interest on pH 6.0 and 6.5: at pH6.0, the stable i-motif structure can exist in all
PEG8000 containing buffers, except in BPES buffer with no additional PEG8000, and the
stability of the i-motif structure increases as the concentration of the PEG8000 contained in
the solution increasing; at pH 6.5, the stable i-motif structure can only exist in 30% w/w
PEG8000 containing buffer, and it has the highest stability, in terms of melting
temperature. The DSC results indicate that the stability of i-motif structure is proportional
to the concentration of the added macromolecule, in those cases where the stable i-motif
structure can be formed.
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Figure 3.6

A plot of the measured melting temperatures (Tms) of the DNA structure
formed by the mutant human c-MYC promoter C-rich sequence in various
buffer solutions at five specific pH values (4.5, 5.0, 5.5, 6.0 and 6.5).

Notes: Black: Tms in BPES buffer with no PEG8000; Red: Tms in BPES buffer with 20%
w/w PEG8000; Green: Tms in BPES buffer with 30% w/w PEG8000; Blue: Tms in BPES
buffer with 40% w/w PEG8000.
A DSC melting curve for the DNA structures formed by the mutant human cMYC promoter sequence at pH 5.0 in 40% w/w PEG8000 solution is shown in Figure 3.7.
The red line is the melting curve for the stable i-motif structure while the blue line is
assumed to be the melting curve of the DNA/PEG complex, and the black line is the sum
of these two melting curves. The complex is considered to be more stable (having a
higher melting temperature), since the Tm is higher than the reported intramolecular imotif structure. The speculation is that the complex is made up of more than one DNA
sequence trying to form an intermolecular i-motif structure with some PEG8000 pieces
winding around it by non-covalent interactions. Unfortunately, we could not prove the
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structure of the complex. Figure 3 is an example of the melting curve for the mixture of imotif and complex. The complex does not only exist at pH 5.0, but in all 40% w/w
PEG8000 solutions.

Figure 3.7

A DSC melting curve for the DNA structures formed by the mutant human
c-MYC promoter sequence at pH5.0 in 40% w/w PEG8000 solution.

Notes: Red: the melting curve for the i-motif structure; Blue: the melting curve for the
DNA/PEG complex; Black: the sum of the two melting curves.
Figure 3.8 shows a plot of the molar ellipticity at 286 nm versus pH for the C-rich
c-MYC DNA promoter sequence in 0%, 20%, 30% or 40% PEG8000. The CD data used to
make this plot indicate that this DNA can form an i-motif in each of these solutions, at
least at pH values below 6.0. The inflection point of each titration shows the highest pH
value where the i-motif structure exists. The pH of the titration inflection point increases
with increasing concentration of the PEG8000, at least for PEG containing solutions
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having concentrations below 40% w/w.

These trends and the upper limit pH values in

each solution are in excellent agreement with our previous observations. The data in
Figure 3.8 also shows that in the 40% w/w PEG8000 solution, the apparent molar
ellipticity for the i-motif is decreased. This result is explained by a reduction in the imotif concentration in these solutions due to the formation of non-specific DNA/PEG
complexes. In effect, as the PEG8000 concentration is increased above 30%, the formation
of DNA/PEG complexes effectively reduces the i-motif DNA concentration by shifting
the i-motif folding/unfolding equilibrium toward more unfolded DNA and less i-motif.

Figure 3.8

DNA molar ellipticity at 286 nm verses pH for each base titration of the
DNA structure formed by the mutant human c-MYC promoter sequence in
0-40% PEG8000 containing buffers.

Notes: Black: CD titration was done w/o added PEG. Red: CD titration was done in 20%
w/w PEG8000. Green: CD titration was done in 30% w/w PEG8000. Blue: CD titration was
done in 40% w/w PEG8000.
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In order to determine whether the CD pH titrations were reversible, and to learn
something about the kinetics of the folding unfolding process in the presence or absence
of molecular crowding agents, the titrations shown in Figure 3.8 were repeated in both
directions, i.e. going from low to high pH by the addition of NaOH and going from high
pH to low pH by the addition of HCl. One of these cyclic titrations is shown in Figure
3.9. There is no hysteresis observed in these CD titrations, in other words the acid and
base titrations are virtually super-imposable. Within the time response of these CD
titration experiments (< 60 seconds), these experiments were completely reversible, and
there was no evidence that these systems were not at equilibrium.
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Figure 3.9

DNA molar ellipticity at 286 nm verses pH for each acid or base titration of
the DNA structure formed by the mutant human c-MYC promoter
sequence in 30% PEG8000.

Notes: Black: CD titration was done by the addition of 1.0 M NaOH. Red: CD titration
was done by the addition of 1.0 M HCl to 30% w/w PEG8000.
In Figure 3.10, DSC melting curves of the i-motif structure formed in 0%, 10%,
20% and 30% w/w PEG12000 buffers at pH 5.0 and 6.0. The melting temperatures are also
listed in the figures. The DSC results show that at both pH 5.0 and 6.0, the stability of the
i-motif structure, in terms of melting temperature, increases as the concentration of
PEG12000 increases. This observation is consistent with the results of the i-motif stability
in PEG8000 buffers with concentrations from 0% to 30%, indicating that the greater
excluded volume effect caused by the higher concentration of macromolecule in the
buffer will further stabilize the i-motif structure. If we compare the melting temperatures
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of the i-motif structure in two different PEG containing buffers (PEG8000 and PEG12000),
but having the same concentration and the same pH values (see Table 3.1 and Figure 3.10
A and B), we can notice that at the same concentration (20% and 30% w/w), PEG8000
could better stabilize the i-motif structure, by presenting higher melting temperatures in
pH 5.0 solutions, while PEG12000 stabilized the i-motif structure at pH 6.0: at pH 5.0, the
melting temperature of i-motif structure in 20% PEG8000 buffer (Tm20% PEG8000) is 50.35˚C
> Tm20% PEG12000 = 48.46˚C; Tm30% PEG8000 = 52.52˚C > Tm30% PEG12000 = 51.01˚C. At pH 6.0,
Tm20% PEG8000 = 32.45˚C < Tm20% PEG12000 = 36.77˚C; Tm30% PEG8000 = 42.30˚C < Tm30%
PEG12000 =

46.70˚C. This observation indicates that the molecular weight of the

macromolecule in the buffer is not always proportional to the stability of the i-motif
structure. From the DSC melting data of the DNA samples in all the PEG12000 buffers, no
matter the concentrations, we noticed the same melting curves for the DNA/PEG
complex, as described earlier (Figure 3.7) in this dissertation (melting curves not shown).
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Figure 3.10

The DSC melting curves of the i-motif structure formed in 0%, 10%, 20%
and 30% w/w PEG12000 solutions at pH 5.0 and 6.0.

The drop in the melting temperature in PEG12000 solutions and the existence of
complex suggest that there may be a competition reaction, the formation of the complex,
happening at the same time. The formation of the complex could be favored in buffers
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containing higher molecular weight PEG, due to the extreme crowded effect, making the
complex more stable than the i-motif structure.
Figure 3.11 (A-D) shows the spectra of the CD titration experiments applied to
the DNA structure formed by mutant human c-MYC promoter sequence in 0-30% w/w
PEG12000 containing buffer solutions (A, 0%; B, 10%; C, 20%; D, 30%). The CD results
show that in 10%, 20% and 30% PEG12000 solutions, the highest pH to maintain a stable imotif are around pH 6.1, pH 6.2, and pH 6.3, respectively. Compared with the CD
titration data of PEG8000 solutions (see Figure 3.5), there is a big difference: at the same
concentration, PEG8000 solutions maintain a stable i-motif structure at higher pH values
than PEG12000 solutions. This observation also suggests that the i-motif structure is
destabilized in high molecular weight PEG containing buffers, and this may be due to the
formation of the DNA/PEG complex.
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Figure 3.11

The spectra of the CD titration experiments applied to the DNA structure
formed by mutant human c-MYC promoter sequence in 0-30% w/w
PEG12000 containing buffer solutions (A, 0%; B, 10%; C, 20%; D, 30%).
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Figure 3.11 (continued)
Notes: A: Black: pH 4.50; Red: pH 5.60; Orange: pH 5.75; Yellow: pH 5.81; Light green: pH 5.84; Dark
green: pH 5.92; Light blue: pH 5.99; Dark blue: pH 6.08; Purple: pH 6.21. B: Black: pH 4.09; Red: pH
5.75; Orange: pH 5.90; Yellow: pH 5.95; Light green: pH 6.06; Dark green: pH 6.11; Light blue: pH 6.17;
Dark blue: pH 6.29; Purple: pH 6.50; Pink: pH 7.00. C: Black: pH 4.05; Red: pH 5.81; Orange: pH 6.00;
Yellow: pH 6.05; Light green: pH 6.14; Dark green: pH 6.22; Light blue: pH 6.30; Dark blue: pH 6.45.
Purple: pH 6.63. Pink: pH 6.72. D: Black: pH 4.93; Red: pH 5.79; the Orange: pH 6.03; Yellow: pH 6.16;
Light green: pH 6.25; Dark green: pH 6.34; Light blue: pH 6.39; Dark blue: pH 6.47; Purple pH 6.54. Pink:
pH 6.91.
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CHAPTER IV
DISCUSSION

I-motif structures formed by the C-rich sequences, that are complementary to the
G-quadruplex forming strand in oncogene P1 promoter regions, e.g c-MYC, Bcl-2, and
K-ras, have been proposed as novel drug targets for the treatment of cancer and other
diseases. The hypothesis is that the binding of small molecules to a looped out promoter
region i-motif could interfere with transcription of the oncogene resulting in
downregulation of oncogene expression. The viability of this idea is based, at least in
part, on the premise that a stable i-motif structure can be formed at neutral pH in the
crowded nuclear environment.
In this work, we set out to evaluate the effects of added co-solute and/or
molecular crowding agents on c-MYC i-motif stability at neutral pH. The intent was to
determine whether a C-rich sequence like that found in the c-MYC promoter region could
be stabilized to exist as an i-motif at neutral pH in a crowded solution environment like
the cell nucleus. Polyethylene glycol, PEG, having an average molecular weight from
200 g/mol to 12,000 g/mol, was added at concentrations of 10% to 40% to model the
solute proteins and nucleic acids present in the nuclear solution. Glycerol was also
employed as a co-solute in an attempt to differentiate between typical co-solute effects,
i.e. the reduction in water activity and lower bulk solvent dielectric constant, and the
molecular crowding effects of the higher molecular weight PEG co-solutes.
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Co-solute effects vs. excluded volume effects
CD and DSC experiments indicated that the addition of either glycerol or PEG200
(both at 20% w/w), produced similar effects on the stability and the folding equilibria of
the c-MYC i-motif. There are however subtle differences in the effects of these two cosolutes. To understand these differences, we first discuss the role of the simple co-solute
glycerol on both stability and folding equilibria at different pH values. As shown in
Figure 3.3 the presence of glycerol destabilizes the i-motif at lower pH values where the
cytosine pairs {Cyt-3N+-H / H-+N3-Cyt} are fully protonated. This is the obvious result
of the {Cyt-3N+-H / H-+N3-Cyt} repulsion being greater in the lower dielectric constant
environment of the 20% glycerol-water mixed solvent. The opposite effect would be
observed at higher pH values where the attractive coulombic interaction responsible for
formation of the third hydrogen bond in the hemiprotonated {Cyt-3N+-H / N3-Cyt} pair
will result in i-motif stabilization. The co-solute effect of the added glycerol can be
attributed almost solely to its effect on strengthening the coulombic interactions (both
attractive and repulsive) through its lowering of the effective dielectric constant of the
mixed solvent.
A similar co-solute effect is also observed in the DSC results for the thermal
denaturation of the i-motif structure in 20% PEG200 solutions. At pH 4.0, the i-motif
structure is destabilized in all four PEG containing buffers, while at pH 4.5 or higher, the
stability of the i-motif structure is increased as is evident from the increased Tm (see
Figure 3.1).
The excluded volume effect of the 20% PEGs at these two pH values would be
the same, the only possibility to cause the difference of the i-motif melting temperature is
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the co-solute effect. In comparison to 20% glycerol, the 20% PEG containing solutions
have a very similar dielectric constant (ε20% PEG =75.08; ε20% Glycerol=74.72). It means that
in the PEG containing solutions, there are also large repulsive coulombic forces between
the {Cyt-3N+-H / H-+N3-Cyt} pairs which contribute to the destabilization of the imotif structure at pH values below the cytosine pKa (e.g. pH 4.0, cytosine pKa=4.6).
This increase in the strength of the coulombic interactions is offset somewhat by the
crowding of the higher molecular PEGs which are stabilizing the more compact i-motif
structure over the random coil structure. This is the reason that the decrease in the
melting temperatures in PEG containing solutions are not as dramatic or obvious as in the
glycerol solution. In the PEG containing solutions (particularly for the PEG1000 and up)
the excluded volume effect works to stabilize the i-motif structure at the same time the
co-solute effect is in play to destabilize it. The combination of these two opposite effects
attenuates the decrease in the i-motif melting temperature when comparing pH 4 buffer to
glycerol containing solutions vs. pH 4 buffer to higher molecular weight PEG containing
solutions.
The excluded volume effect also contributes to the increase in the melting
temperatures for the i-motif structure in 20% PEG containing buffers at pH 4.5-6.0. In
this pH range, the {Cyt-3N+-H / H-+N3-Cyt} pair repulsive effect is diminished at the
same time the H-bonding in hemi-protonated {Cyt-3N+-H / N3-Cyt} pair is strengthened.
The addition of PEG to the buffer increases the stabilization of i-motif structure by both
increasing the strength of the hydrogen bonding and in the case of the larger PEGs also
increasing the molecular crowding due to their excluded volume effect. In comparing the
melting temperatures of the i-motif structure in buffer alone vs. the melting temperatures
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in PEG containing buffers (particularly for the higher molecular weight PEGs), the Tms
are increased in every case. Molecular crowding, a result of the excluded volume of the
higher molecular weight co-solutes, is stabilizing the i-motif, with the stabilization
increasing with both co-solute concentration and co-solute molecular weight.
The effect of the PEG concentration on the i-motif stability
The CD and DSC results for the DNA structure formed by the mutant human cMYC promoter sequence in BPES buffers containing 0-30% w/w PEG8000 show that
there is a direct relationship between the concentration of PEG8000 and the stability of the
c-MYC i-motif. The i-motif structure has the highest melting temperature in buffer
containing 30% w/w PEG8000. In these solutions, the i-motif structure persists and is
stable in solutions having pH values of up to 6.7 or 6.8. Unfortunately the increase in imotif stability with increasing concentration of the molecular crowding agent is limited.
Once the concentration of PEG8000 reaches 40% w/w, there is unexpected DNA/PEG
complex formation. CD titrations and DSC results demonstrate the existence of the nonspecific DNA/PEG complex. Once the conditions promoting complex formation are
reached, and the concentration of the stable i-motif is reduced and the upper limit pH
where the stable i-motif persists is also reduced.
Based on previous results, we speculate that there is a competition between the
formation of stable i-motif and the formation of DNA/PEG complex in 40% PEG8000
buffer. In acidic condition (pH < 6.1), the formation of the i-motif predominates while at
higher pH values the DNA/PEG complex is the major species in solution. The stable imotif in the 40% PEG8000 is detectable by CD and in the appropriate pH range it exhibits
the highest melting temperature for the i-motif in any solution studied. Again there are
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several forces that may be in play including any remaining attractive interactions between
the hemi-protonated {Cyt-3N+-H / N3-Cyt} pairs at the higher pH (pH ≥ 6.1), the
excluded volume effect on the i-motif from the high concentration of the PEG8000, and or
the pH and concentration driven association of the PEG and DNA polymers. At pH 6.1 or
higher, the formation of the DNA/PEG complex begins to take over and at this pH the
cytosine pairs are only fractionally protonated. This combination renders a change in the
species distribution wherein the complex predominates and the i-motif structure although
stable is depleted in favor of the complex. The equilibrium between the folded and
unfolded i-motif structures is pulled toward more unfolding by the fact that the unfolded
sequence is taken out of the equilibrium by formation of the DNA/PEG complex. This
explains the decrease in the Tm at pH 6.5 in 40% PEG8000 buffer: where we actually see
two melting profiles in the DSC, a lower Tm was for the partially unfolded i-motif like
structure and a higher Tm was DNA/PEG complex.
In conclusion, the concentration of the macromolecule contributes to the stability
of i-motif structure both in terms of increasing the melting temperature and increasing the
the upper limit pH where the i-motif remains a stable structure, pH ≈ 6.8 for 30% PEG
solutions and pH ≈ 6.1 for 40% PEG solutions. As the concentration of molecular
crowding agent becomes high enough to favor complex formation, the stabilization of the
i-motif through the excluded volume effect is compromised by the non-specific
interaction between the DNA and the polyethylene glycol.
The effect of the PEG size on the i-motif stability
From the 20% PEG experiments, we see a trend in increased stability of the imotif with increasing molecular weight of the PEG co-solute. In effect, increased
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stabilization of the i-motif, as measured by increased i-motif melting temperature
followed the regular trend: PEG200 ≤ PEG400 ≤ PEG1000 ≤ PEG2000 ≤ PEG4000 ≤
PEG8000. The 20% PEG8000 fell in line with the lower molecular weight PEGs in that the
melting temperature of i-motif in 20% PEG8000 containing buffer is the highest at all pH
values in comparison with all other 20% PEG buffers. However, when we further
increased the molecular weight of the of the PEG crowding agent to 12,000 g/mole, we
encountered DNA/PEG complex formation even in 20% w/w solutions. DNA/PEG
complexes were formed in every DNA sample made in every PEG12000 containing buffer
even at PEG concentration as low as 10%. Obviously high concentrations of the PEG8000
or even low concentrations of PEG12000 can result in the non-specific interactions (or
entanglements) responsible for complex formation and thus destabilization of the i-motif
structure. PEG is a synthetic polymer chain and the polymer chain length is directly
proportional to the polymer molecular weight. We speculate that the longer PEG chains
in the solution can entangle with the unstructured DNA strands to form the non-specific
complex. Significant concentrations of the DNA/PEG complex were founded even in
10% PEG12000 containing buffers. This fact may suggest that the size of the
macromolecule may be more responsible for complex formation than the concentration
although both contribute in the most crowded solutions. Due to the larger excluded
volume effect of the higher molecular weight PEG, the complex formation appears to
compete with i-motif formation and stabilization across the pH range.
One observation that we have made is that thermal denaturation (unfolding) of the
i-motif under conditions where the i-motif is most stable (pH 4.5 to pH 5.5) follows a
“two-state” mechanism, in other words the denaturation does not show any cooperativity.
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An example of the differences in the DSC curves for a “two-state” melt versus a “nontwo-state” process exhibiting positive cooperativity is shown in the simulated DSC data
given in Figure 4.1.

Figure 4.1

Two simulated DSC melting curves are shown as an example to indicate
the differences between the “two-state” melt versus (no cooperativity,
ΔHVH/ ΔHcal = 1) and the “non-two-state” process (positive cooperativity,
ΔHVH/ ΔHcal = 2).

The positive cooperativity of the melting is observed as a Van’t Hoff enthalpy
change, ΔHVH, that is larger than the calorimetric enthalpy change, ΔHcal. The positive
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cooperativity is observed as a narrower sharper and taller peak in the excess heat capacity
curve obtained in the DSC experiment and its interpretation in this case would be that
once the DNA structure begins to unzip it is easier to unzip it further. The “two-state”
model in which the only species present would be the completely folded or completely
unfolded i-motif sequences would exhibit a (ΔHVH/ΔHcal) ratio approximately equal to
1.0. In Figure 4.2, we have plotted the (ΔHVH/ΔHcal) ratio observed for the melting of the
i-motif at several pH values and in the presence or absence of added co-solutes.

Figure 4.2

A plot that shows the (ΔHVH/ΔHcal) ratio observed for the melting of the imotif at several pH values and in the presence or absence of added cosolutes.

Notes: Black: BPES buffer. Red: 20% w/w glycerol solutions. Blue: 20% w/w PEG200
solutions. Green: 20% w/w PEG8000 solutions.
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It is clear that the melting of the i-motif at pH 4.0 is highly cooperative in that the
(ΔHVH/ΔHcal) ratio is significantly larger than 1.0 in all of the solutions shown. What this
means is that the i-motif destabilization at this pH is such that once an intercalative
hydrogen bond is broken the other intercalative hydrogen bonds are weakened and the imotif falls apart. Even in the presence of PEG8000, the crowding effect cannot provide
much stability. The glycerol data show the highest cooperativity for melting at pH 4 and
of course the lowest stability. It is interesting that the cooperativity for i-motif melting is
positive at all pH values in glycerol. Is this a result of better solvation of exposed
cytosines in the glycerol containing buffer than in either the buffer without co-solute or in
the PEG solutions? That remains a question. It is also interesting to note that in the pH
region where the i-motif is stabilized the melting mechanism is almost certainly “twostate” and that departure from the “two-state” model is only seen as positive cooperativity
and is only observed at the pH extremes.
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CHAPTER V
CONCLUSIONS

In this work, we probed the influence of both low molecular weight co-solutes
and high molecular weight crowding agents on the stability of the c-MYC C-rich
promoter sequence i-motif in crowded environments at neutral pH. Low molecular
weight co-solutes included glycerol and 200 and 400 g/mole PEG. The crowded
environment of the nucleus was simulated by higher molecular weight PEGs at
concentrations as high as 40% w/w. We were able to demonstrate that the smaller cosolutes had the effect of improving charge stabilization through both a reduction in the
water activity and an increase in solvent dielectric properties stability.
Although not measured, we can estimate that the folded i-motif is considerably
smaller than the DNA random coil. In effect the i-motif to coil transition requires
greater energy in these solutions to unfold the DNA than would be needed in water.
We started this work with the idea of answering just one question, can an i-motif exist as
a stable structure at neutral pH. In the presence of 30 % w/w PEG8000 , the i-motif was
found to be stabile in solutions having pH values as high as 6.7 or 6.8, fairly close the
pH=7 we were trying to achieve. Although PEG has been used extensively in the
literature to explore molecular crowding in cells and sub-cellular organelles, its use in
these studies was less successful. We found that stabilization of the DNA i-motif by
PEG, especially at higher molecular weight PEGs (8000 to 12,000 g/mole), was offset to
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some degree by the non-specific interaction of the DNA random coil and the higher
molecular weight PEGs. The best result we achieved was in 30% w/w PEG8000 solution
where stable i-motif structure was able to exist at pH as high as 6.7 or 6.8. In these
solutions, the i-motif still had a characteristic CD signal and a melting temperature in
excess of 38˚C. Unfortunately, once the concentration of PEG8000 is increased to 40%
w/w or more, or the PEG molecular weight is increased beyond 12000 g/mole, the
formation of DNA/PEG complexes destabilizes the i-motif.
Nevertheless, we predict that stable i-motif structures can be formed under
physiological conditions. It is clear that the ΔH for unfolding the i-motif is positive and
that crowding due to excluded volume effects must stabilize the more compact i-motif
relative to the random coil DNA. Our explanation is that the intracellular environment is
crowded by relatively high concentrations of biopolymers (protein, DNA, RNA,
metabolytes etc.) in an aqueous solution wherein the water concentration is quite low
(certainly < 60% w/w). We speculate that the use of uncharged PEG to model this
environment is just too simple. Although we have not proven the formation of a stable cMYC (or other oncogene) i-motif under physiological conditions, it seems that continued
targeting of the i-motif, is still a viable and novel approach to cancer treatment.
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